img Leseprobe Leseprobe

Epigenetics and Disease

Pharmaceutical Opportunities

Susan M. Gasser (Hrsg.), En Li (Hrsg.)

PDF
ca. 213,99
Amazon iTunes Thalia.de Weltbild.de Hugendubel Bücher.de ebook.de kobo Osiander Google Books Barnes&Noble bol.com Legimi yourbook.shop Kulturkaufhaus ebooks-center.de
* Affiliatelinks/Werbelinks
Hinweis: Affiliatelinks/Werbelinks
Links auf reinlesen.de sind sogenannte Affiliate-Links. Wenn du auf so einen Affiliate-Link klickst und über diesen Link einkaufst, bekommt reinlesen.de von dem betreffenden Online-Shop oder Anbieter eine Provision. Für dich verändert sich der Preis nicht.

Springer Basel img Link Publisher

Naturwissenschaften, Medizin, Informatik, Technik / Klinische Fächer

Beschreibung

Epigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. Epigenetic misregulation is thus often linked to degenerative diseases, cancer and neuronal disorders. Recent biomedical interest in this regulatory system stems from the fact that epigenetic, in contrast to genetic, alterations are in principle amenable to pharmacological intervention. A few epigenetically active drugs, for example histone deacetylase inhibitors (HDACi) and DNA methyltransferase (DNMT) inhibitors, have been approved by FDA for treatment of cancers such as CTCL, MDS, and AML. This volume explores the scientific background for clinical applications of epigenetically active drugs. Included are descriptions of epigenetic controls over gene expression, the post-transcriptional silencing of genes by RNA interference (RNAi) and microRNAs, as well as new findings from stem cell research which are relevant to pharmacological applications.

Weitere Titel in dieser Kategorie
Cover Dallas Rhinoplasty
William P. Adams Jr.
Cover Dallas Rhinoplasty
William P. Adams Jr.
Cover Heart
Paddy Barrett
Cover Asphyxia in Neonates
Miljana Z. Jovandaric

Kundenbewertungen

Schlagwörter

DNA methylation, therapy, neuronal disorders, stem cells, cancer